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Abstract Zinc oxide (ZnO) is a semiconductor
compound with a potential for wide use in various
applications, including biomaterials and biosensors,
particularly as nanoparticles (the size range of ZnO
nanoparticles is from 2 to 100 nm, with an average of
about 35 nm). Here, we report isolation of novel ZnO-
binding peptides, by screening of a phage display
library. Interestingly, amino acid sequences of the
ZnO-binding peptides reported in this paper and those
described previously are significantly different. This
suggests that there is a high variability in sequences of
peptides which can bind particular inorganic mole-
cules, indicating that different approaches may lead to
discovery of different peptides of generally the same
activity (e.g., binding of ZnO) but having various
detailed properties, perhaps crucial under specific
conditions of different applications.
Keywords Zinc oxide  ZnO nanoparticles 
ZnO-binding peptides  Phage display
Introduction
Zinc oxide (ZnO) is a compound widely used in many
applications, including construction of solar cells,
luminescent materials, and acoustic devices (Goyal
et al. 1992; Ezhilvalavan and Kutty 1997; Yu et al.
2005; Shinde et al. 2007). Interestingly, employment
of ZnO in biosensors has also been proposed (Gerstel
et al. 2006; Park et al. 2009; Tomczak et al. 2009). The
possibility to obtain ZnO nanoparticles (i.e., the
structures whose at least one dimension is less than
100 nm) significantly broads its practical usefulness
(Fan and Lu 2005). It appears that ZnO nanoparticles
(which are usually in the size range between 2 and
100 nm, with an average of about 35 nm; Meulenk-
amp 1998) may be of special interest in biotechnology
and nanotechnology (Umetsu et al. 2005; Okochi et al.
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2010). In fact, ZnO nanomaterials have been used in
sensors, field emission devices, photodetectors, and
optical switches (for a review, see Weintraub et al.
2010). Medical applications of ZnO nanoparticles are
facilitated due to consideration of ZnO as a safe
material, and include anticancer agents, antimicrobial
factors, and drug delivery systems (discussed by Li
et al. 2008 and Rasmussen et al. 2010). Since ZnO
nanoparticles can absorb UV light, they are used in
cosmetics, particularly in face or body sunscreen
creams (Rasmussen et al. 2010).
The wide use of ZnO nanoparticles stimulated the
search for compounds that may specifically bind such
structures. In fact, agents that can bind inorganic
compounds may be used to build materials with
nanoscale precision. Peptides and proteins were dem-
onstrated to be particularly useful in this approach,
even when applied to substances not commonly found
in biological systems (Brown et al. 2000). Therefore,
knowing an extremely high variability of properties of
peptides and proteins, and a potential possibility to
obtain a peptide that might bind any small molecule of
interest, it is reasonable to search for peptides
specifically interacting with certain compounds (Seker
and Demir 2011). One of the most effective methods
in such a search, especially if a target material forms
nanoparticles, is screening of peptide libraries (Seker
and Demir 2011).
Phage display technique is a method which allows
production of various peptides attached to the surface
proteins of bacteriophage virions (Castel et al. 2011).
This is achieved by genetic engineering of the
bacteriophage genome, particularly by fusing genes
coding for phage structural proteins with an appropri-
ate DNA fragment, coding for the desired protein or
peptide. This may concern either a specific peptide or
protein of known functions or a putative one. In the
latter case, DNA fragments of randomized sequences
can be cloned, and their expression leads to formation
of a peptide library, expressed on the bacteriophage
surface. Derivatives of phage M13 are among the most
widely used vectors in phage display systems (Geor-
gieva and Konthur 2011).
Previously, several ZnO-binding peptides have
been reported, which were isolated on the basis of
various approaches, including screening of peptide
libraries expressed in phage display systems (Kjærg-
aard et al. 2000; Umetsu et al. 2005; Okochi et al.
2010; Vreuls et al. 2010). Amino acid sequences of
these peptides are listed in Table 1. We wanted to
probe whether amino acid sequences of ZnO-binding
peptides are strictly determined (i.e., the number of
possible kinds of ZnO-binding peptides of various
sequences is strictly limited) or whether there are
many possibilities to form such peptides, whose
sequences are significantly different. If the former
alternative is true, any new attempts to obtain ZnO-
binding peptides should result in obtaining results
similar to those published to date. On the other hand, if
the latter option is correct, new experiments, differing
even slightly in details, should result in isolating
peptides which bind ZnO but have amino acid




In order to isolate novel ZnO-binding peptides, we
have employed a peptide phage library that displays a
linear 12-mer peptide on the pIII protein of M13KE
phage (Ph.D.-12 Phage Display Peptide Library Kit,
New England Biolabs, NEB). This system was
successfully used previously to find material-specific
peptides (Whaley et al. 2000; Chen et al. 2006; Ahmad
et al. 2008).
Selection and characterization of bacteriophages
presenting ZnO-binding peptides
In order to select bacteriophages presenting ZnO-
binding peptides on their surfaces, we have utilized
synthetic, physically powdered ZnO (Sigma-Aldrich).
Panning procedure was performed according to the
Phage Display Manual (NEB). Briefly, 10 mg of ZnO
powder were washed six times with the TBST buffer
(50 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.1 %
Tween-20) to remove any ZnO particles that do not
sediment during centrifugation at 4,000 9 g for 1 min
(which would negatively interfere with phage isola-
tion at later steps of the procedure) and to establish the
equilibrium of buffer conditions of the mixture (which
is crucial for effective binding of phages to any
surface). 10 lL of phage library was incubated with
ZnO in 1 mL of the TBST buffer (at final ZnO
concentration of 10 mg/mL) for 1 h at room
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temperature (RT). This incubation time was chosen on
the basis of results of preliminary experiments, in
which shorter incubation was less efficient in isolating
ZnO-binding phages, while extending the time over 1
h did not change the results significantly. Unbound
phages were then separated from ZnO-binding phages
by centrifugation (4,000 9 g, 1 min, RT) and were
subsequently removed by decanting the supernatant.
The pellet containing ZnO with bound phages was
washed ten times with the TBST buffer. Phages which
bound ZnO were eluted with 1 mL of 0.2 M glycine–
HCl (pH 2.2) for 10 min, and finally neutralized with
150 lL of 1 M Tris–HCl (pH 9.1). Phages were then
multiplied on Escherichia coli ER2738 (NEB) accord-
ing to the NEB protocol and used in the next panning
procedure (briefly, for phage multiplication, 0.2 mL of
an overnight E. coli ER2738 culture were mixed with
eluted phages, transferred to 20 mL of fresh LB
medium in a 250 mL flask, and incubated with shaking
(160 rpm) at 37 C for 5 h). Three rounds of panning
were performed. Following the last panning, the eluted
phages were titrated on agar plates supplemented with
IPTG/XGal as previously described (Łos´ et al. 2008).
Phages from individual plaques were amplified as
described above, and their DNAs were isolated and
purified according to Wilson (1993) and sequenced
commercially using the 96 gIII sequencing primer
(NEB).
Results and discussion
Experiments performed as described in Materials and
methods led to detection of a huge variability (in the






PG-2 TMGANLGLESPE 3.79 Affinity of PG-2 to ZnO is at least 10 times lower than those
of PG-7, PG-8, PG-10, PG-12, PG-14 and PG-17
This report
PG-7 TMGANLGLKWPV 8.41 The consensus sequence determined in this report This report
ZnO-1 EAHVMHKVAPRP 8.86 Affinity of ZnO-1 to ZnO is at the same level as that of PG-7 (Umetsu et al. 2005)
ZnO-2 QNTATAVSRLSP 9.75 Affinity of ZnO-2 to ZnO is at least 100 times lower than that
of ZnO-1
(Umetsu et al. 2005)
ZnO-3 ATHTNQTHALYR 8.80 Affinity of ZnO-3 to ZnO is at least 100 times lower than that
of ZnO-1
(Umetsu et al. 2005)
ZnO-4 VSNHKALDYPTR 8.57 Affinity of ZnO-4 to ZnO is at least 100 times lower than that
of ZnO-1
(Umetsu et al. 2005)
ZnO-5 DSGRYSMTNHYS 6.74 Affinity of ZnO-5 to ZnO is at least 100 times lower than that
of ZnO-1




HVNLHS 6.92 Affinity of ZnO Okochi-1 to ZnO is at the same level as that
of ZnO-1




RCARRY 10.76 Affinity of ZnO Okochi-2 to ZnO is at the same level as that
of ZnO-1




HYQSNW 6.74 Affinity of ZnO Okochi-3 to ZnO is at the same level as that
of ZnO-1




HWFHPR 9.76 Affinity of ZnO Okochi-4 to ZnO is at the same level as that
of ZnO-1




VRTRDDARTHRK 11.54 This peptide has been found with the use of the FimH display
system
(Kjærgaard et al.
2000; Vreuls et al.
2010)
a Isoelectric point had been calculated using pI/mass program at http://ca.expasy.org
b Names have been given by authors of this work, as no specific names were used in the original publications
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range of a few to several orders of magnitude) in
efficiencies of binding to ZnO nanoparticles exhibited
by different phage clones, as estimated by determining
percentages of bound and unbound virions after 1 h
incubaction. In fact, some binding (several percent of
bound virions) could be observed even for phages that
did not expose any foreign peptides on their capsids
(data not shown). This might be explained by the fact
that no chemical surface could be truly neutral in its
effects on adhesion, thus, even naturally occurring
phages may attach, to some extent, to any particles.
Nevertheless, we have isolated 20 phage clones which
were able to bind ZnO very efficiently, i.e., in which at
least 99.99 % virions were able to interact with ZnO
sufficiently stably to remain bound after the washing
procedures.
Of the isolated 20 clones, those revealing the
highest affinity to ZnO (clones no. PG-7, PG-8, PG-10,
PG-12, PG-14, PG-17) were chosen for more detailed
analysis, in which nucleotide sequences of the DNA
inserts have been determined. As a semi-negative
control, a clone revealing about ten times lower
affinity to ZnO (measured as a fraction of virions able
to remain bound after the washing procedures), called
clone no. PG-2, was also analyzed (Fig. 1). Amino
acid sequences of peptides PG-7, PG-8, PG-12,
PG-14, and PG-17, exposed on the phage surface,
deduced on the basis of determined nucleotide
sequences, were identical and red as follows:
TMGANLGLKWPV (Fig. 1; Table 1). The amino
acid sequence of PG-10 was TTGANLGPKWPV, and
that of PG-2 was TMGANLGLESPE. Comparison of
the differences between clones binding ZnO relatively
strongly (i.e., consisting of less than 1 per 105 virions
unbound to ZnO, giving the efficiency of binding
[99.999 %; clones PG-7, PG-8, PG-12, PG-14, and
PG-17) with those binding ZnO slightly (clone PG-10)
or significantly (clone PG-2) weaker indicated that the
 Fraction of   Efficiency of 
    ZnO-unbound  ZnO binding 
    virions   (% of phages) 
PG-2:  TMGANLGLESPE 1.33 x 10-4       99.99  
PG-7:  TMGANLGLKWPV  < 1 x 10-5    > 99.999
PG-8:  TMGANLGLKWPV  < 1 x 10-5    > 99.999 
PG-10: TTGANLGPKWPV  1.16 x 10-5     99.998 
PG-12: TMGANLGLKWPV  < 1 x 10-5   > 99.999 
PG-14: TMGANLGLKWPV  < 1 x 10-5   > 99.999 
PG-17: TMGANLGLKWPV  < 1 x 10-5   > 99.999 
________________________________________________________________ 
Consensus: TMGANLGLKWPV     > 99.999 
Fig. 1 Characterization of selected phage clones which expose
ZnO-binding peptides on their virion surfaces. Names of clones
and sequences of the exposed peptides are shown, with
differences in amino acid residues between peptides marked
by white letters on the black background. Efficiency of ZnO
binding by particular phage clones was estimated by determi-
nation of the fraction of virions unbound to ZnO after the
washing procedure (see Materials and methods for details)
Fig. 2 Efficiency of ZnO binding by the phage exposing the
PG-7 peptide on the pIII protein of the M13KE phage. In the
control experiments, the unmodified M13KE phage was used.
The presented results are average values from three experiments
with SD represented by error bars
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optimal amino acid sequence of ZnO-binding peptide,
isolated under conditions employed in this study, was
as follows: TMGANLGLKWPV (Fig. 1). Moreover,
it appears that replacement of M with T at position 2
and of L with P at position 8 (as in PG-10) had a minor
effect on ZnO binding, while replacement of K with E
at position 9, W with S at position 10, and V with E at
position 12 (as in PG-2) resulted in a considerable
lower affinity of the peptide to ZnO (Fig. 1).
The clone no. PG-7 (revealing the optimal ZnO-
binding sequence of the phage surface-exposed pep-
tide), has been further characterized. We assessed the
efficiency of ZnO binding according to the panning
procedure (Sano and Shiba 2003). Binding efficiency
was expressed as the ratio of the output phage number
(phages eluted, O) to the input phage number (phages
incubated with ZnO, I), called the output/input (O/I)
ratio. As a control, we employed the M13KE phage
with the wild-type pIII protein (NEB). The results of
such experiments, presented in Fig. 2, confirmed an
efficient binding of the selected peptide to ZnO. This
efficiency appears to be similar to those described
previously for other peptides isolated as agents that
bind ZnO effectively (Kjærgaard et al. 2000; Umetsu
et al. 2005; Okochi et al. 2010; Vreuls et al. 2010).
The results of experiments presented in this report
indicate that by changing either experimental condi-
tions or approach, it is possible to isolate ZnO-binding
peptides of very different amino acid sequences
(compare sequences of ZnO-binding peptides pre-
sented in Table 1). Therefore, it appears that variability
of peptide structures that are able to bind this compound
is very high. This implies potential possibilities of
searching for ZnO-binding peptides revealing various
properties under different reaction conditions. In this
light, it is worth reminding that different applications of
ZnO may require binding of this compound by peptides
under various conditions of temperature, pH, ionic
strength, and others (Umetsu et al. 2005).
Finally, one should note that searching for factors
that can bind certain compounds, particularly when
using the method of phage display-based screening of
peptide libraries, is devoted to bio- and bionano-
technological applications, and in no way represents
processes that occur in nature. The phage display tests
demonstrate a huge biological potential of organisms
rather than mimic actual biological selection, at least
under conditions currently occurring in natural
habitats.
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